02 Jan, 2014The Top 10 Reasons You Should Be Reading Open Exchange from Assay Depot


At Open Exchange, we discuss the latest trends in drug development, techniques, and the pharmaceutical industry.  Here are the top posts from 2013….

Read More

31 Dec, 2013CNS Therapeutics: Restrategizing Pharmaceutical Development


The need for CNS therapeutics is on the rise.  Neurological diseases are expected to increase steadily in the coming years.  Previously, we addressed…

Read More

27 Dec, 2013CNS Therapeutics: Is the Risk Worth the Reward?


More than $2 trillion dollars a year are spent on treatments for CNS disorders.  One in three people over 80 currently has Alzheimer’s…

Read More

24 Dec, 2013Happy Holidays From Assay Depot!

19 Dec, 2013CNS Therapeutics: The Next Blockbuster or Bust?


The BRAIN Initiative1 sponsored by the NIH has pushed neuroscience and technology to center stage with President Obama supporting advancing neuroscience.  But the…

Read More

10 Dec, 2013Quantifying 20 Years of Pharmaceutical Innovation


Is there a way to quantify early drug discovery productivity to improve pharmaceutical innovation?  Pharmaceutical innovation is dependent upon a productive development pipeline. …

Read More

05 Dec, 2013Harnessing Stem Cells for Drug Discovery: Part 3


Stem cells are being used to develop robust, reliable disease models that are advancing our understanding of underlying disease progression and mechanism.  Stem…

Read More

03 Dec, 2013Harnessing Stem Cells for Drug Discovery: Part 2


How are stem cells advancing compound screening and analysis of drug-like properties? Stem cells are emerging as significant reagents in drug development pipelines. …

Read More

22 Nov, 2013Next-Gen Protein Microarrays: The Future of Biomarker Discovery?


Assay Depot invited Dr. Heather Buschman to discuss protein microarrays and the future of biomarker discovery. Dr. Buschman earned her Ph.D. in Molecular…

Read More

14 Nov, 2013The Beginning of a Beautiful Friendship: Clinical Diagnostics & Drug Development


Development of clinical diagnostics is a major target for pharmaceutical companies. Drug development is facing new challenges as it becomes more difficult to…

Read More